MS
Mulakala Sajan Kiran
About Mulakala Sajan Kiran
Data last updated:
Mulakala Sajan Kiran is a Director at Shree Cosmetics Limited (since 2014), Director at Sarvotham Remedies Limited (since 2002) and Director at Cebis India Limited (since 2020), and holds 1 more current directorship. The companies operate in FMCG, Healthcare and Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹5.71 Cr; the largest is Shree Cosmetics Limited at ₹2.79 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shree Cosmetics Limited U24246TG2006PLC110691 | Director | 19 Apr 2014 | 2006 | ₹2.79 Cr (FY 2024) | Active |
 Sarvotham Remedies Limited U24239TG2002PLC038573 | Director | 06 May 2002 | 2002 | ₹1.69 Cr (FY 2025) | Active |
 Cebis India Limited U73100TG2018PLC127550 | Director | 11 Mar 2020 | 2018 | ₹1.22 Cr (FY 2024) | Active |
 Vanta Clinical Research Limited U73100TG2018PLC126673 | Director | 07 Mar 2020 | 2018 | ₹1,983 (FY 2021) | Active |
Board colleagues of Mulakala Sajan Kiran
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dopesh Raja Mulakala | 01176660 | Shree Cosmetics Limited , Cebis India Limited and 1 more | Director |
| Karishma Mulakala | 07828688 | Shree Cosmetics Limited , Sarvotham Remedies Limited | Managing Director |
| Mohan Krishna Mulakala | 01448535 | Shree Cosmetics Limited | Director |
| Sujana Sheela Mulakala | 02265079 | Sarvotham Remedies Limited | Additional Director |
| Chintapatla Shravan | 02698825 | Cebis India Limited , Vanta Clinical Research Limited | Director |
| Yati Brijmohan Chugh | 02966439 | Cebis India Limited | Ceo |
| Yati Brijmohan Chugh | Cebis India Limited | Ceo | |
| Yati Chugh | Cebis India Limited | Ceo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mulakala Sajan Kiran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mulakala Sajan Kiran
Mulakala Sajan Kiran currently holds 4 directorships: Shree Cosmetics Limited (Director, since 19 Apr 2014, revenue ₹2.79 Cr (FY 2024)); Sarvotham Remedies Limited (Director, since 06 May 2002, revenue ₹1.69 Cr (FY 2025)); Cebis India Limited (Director, since 11 Mar 2020, revenue ₹1.22 Cr (FY 2024)); Vanta Clinical Research Limited (Director, since 07 Mar 2020, revenue ₹1,983 (FY 2021)).
Mulakala Sajan Kiran was first appointed on 06 May 2002 as Director at Sarvotham Remedies Limited. The most recent appointment on record is 11 Mar 2020 at Cebis India Limited.
The 4 current companies of Mulakala Sajan Kiran that report revenue have a combined latest revenue of ₹5.71 Cr: Shree Cosmetics Limited ₹2.79 Cr (FY 2024); Sarvotham Remedies Limited ₹1.69 Cr (FY 2025); Cebis India Limited ₹1.22 Cr (FY 2024); Vanta Clinical Research Limited ₹1,983 (FY 2021).
The current boards of Mulakala Sajan Kiran's companies include Dopesh Raja Mulakala (Shree Cosmetics Limited), Karishma Mulakala (Shree Cosmetics Limited), Mohan Krishna Mulakala (Shree Cosmetics Limited), Sujana Sheela Mulakala (Sarvotham Remedies Limited), Chintapatla Shravan (Cebis India Limited), Yati Brijmohan Chugh (Cebis India Limited), among others.